collection
MENU ▼
Read by QxMD icon Read
search

PCI

shared collection
9 papers 25 to 100 followers
By Martin Drew Charge Nurse in cardiac catheter lab
https://www.readbyqxmd.com/read/23500260/colchicine-treatment-for-the-prevention-of-bare-metal-stent-restenosis-in-diabetic-patients
#1
RANDOMIZED CONTROLLED TRIAL
Spyridon Deftereos, Georgios Giannopoulos, Konstantinos Raisakis, Charalambos Kossyvakis, Andreas Kaoukis, Vasiliki Panagopoulou, Metaxia Driva, George Hahalis, Vlasios Pyrgakis, Dimitrios Alexopoulos, Antonis S Manolis, Christodoulos Stefanadis, Michael W Cleman
OBJECTIVES: This study sought to test the hypothesis that colchicine treatment after percutaneous coronary intervention (PCI) can lead to a decrease in in-stent restenosis (ISR). BACKGROUND: ISR rates are particularly high in certain patient subsets, including diabetic patients, especially when a bare-metal stent (BMS) is used. Pharmacological interventions to decrease ISR could be of clinical relevance. METHODS: Diabetic patients with contraindication to a drug-eluting stent, undergoing PCI with a BMS, were randomized to receive colchicine 0...
April 23, 2013: Journal of the American College of Cardiology
https://www.readbyqxmd.com/read/25551527/images-in-clinical-medicine-wellens-syndrome
#2
Lakshmi Kannan, Vincent M Figueredo
A 31-year-old male smoker with diabetes mellitus presented to the emergency department with intermittent, exertional chest pain of 4 days' duration. Electrocardiography performed on arrival (Panel A) revealed anterolateral T-wave inversions with biphasic lateral T waves, which raised concern about..
January 1, 2015: New England Journal of Medicine
https://www.readbyqxmd.com/read/24751502/enhancement-of-myocardial-function-and-reduction-of-injury-with-levosimendan-after-percutaneous-coronary-intervention-for-acute-myocardial-infarction-a-pilot-study
#3
RANDOMIZED CONTROLLED TRIAL
Xiushao Wu, Jing Wu, Xifu Yan, Yanzhou Zhang
OBJECTIVES: To determine the short-term clinical effects of levosimendan in acute myocardial infarction (AMI) patients with myocardial stunning after emergency percutaneous coronary intervention (PCI). METHODS: The study population consisted of 30 patients with AMI who received emergency PCI and satisfied the inclusion criteria. Levosimendan was given as a continuous infusion of 0.1 μg/kg/min for 24 h, and the remaining 10 patients received placebo treatment. The patients were observed with invasive haemodynamic monitoring and were evaluated biochemically and echocardiographically before and after the drug infusion...
2014: Cardiology
https://www.readbyqxmd.com/read/21632912/st-segment-depression-and-t-wave-inversion-classification-differential-diagnosis-and-caveats
#4
REVIEW
Elias B Hanna, David Luke Glancy
Heightened awareness of the characteristic patterns of ST-segment depression and T-wave inversion is paramount to quickly identifying life-threatening disorders. This paper reviews how to distinguish the various causes of these abnormalities.
June 2011: Cleveland Clinic Journal of Medicine
https://www.readbyqxmd.com/read/23277305/reduction-in-first-and-recurrent-cardiovascular-events-with-ticagrelor-compared-with-clopidogrel-in-the-plato-study
#5
RANDOMIZED CONTROLLED TRIAL
Payal Kohli, Lars Wallentin, Eric Reyes, Jay Horrow, Steen Husted, Dominick J Angiolillo, Diego Ardissino, Gerald Maurer, Joao Morais, José C Nicolau, Ali Oto, Robert F Storey, Stefan K James, Christopher P Cannon
BACKGROUND: We sought to evaluate the effect of potent platelet inhibition after acute coronary syndrome on total (ie, first and recurrent) occurrences of any of the primary outcome events (e.g., cardiovascular death, myocardial infarction, and stroke) as well as on other ischemic events, such as urgent revascularization, (severe) recurrent ischemia, transient ischemic attacks, and arterial thrombotic events. METHODS AND RESULTS: In the PLATelet inhibition and patient Outcomes (PLATO) study, 18 624 patients presenting with acute coronary syndromes randomly received ticagrelor (n=9333) or clopidogrel (n=9291)...
February 12, 2013: Circulation
https://www.readbyqxmd.com/read/24077605/therapeutic-strategies-to-prevent-contrast-induced-acute-kidney-injury
#6
REVIEW
Cristina Quintavalle, Elvira Donnarumma, Danilo Fiore, Carlo Briguori, Gerolama Condorelli
PURPOSE OF REVIEW: Contrast-induced acute kidney injury (CI-AKI) accounts for approximately 10% of all causes of hospital-acquired renal failure, causes a prolonged in-hospital stay, and represents a powerful predictor of poor early and late outcome. Here, we highlight endpoints used to assess major strategies to prevent CI-AKI. RECENT FINDINGS: A general consensus exists on the beneficial prophylactic effect of hydration. This seems to act by increasing urine flow rate and, thereby, by limiting the time of contact between the contrast media and the epithelial tubular cells...
November 2013: Current Opinion in Cardiology
https://www.readbyqxmd.com/read/24100651/fractional-flow-reserve-guided-coronary-bypass-surgery-should-surgeons-use-it
#7
REVIEW
T Bruce Ferguson, C Chen, Ashesh N Buch
PURPOSE OF REVIEW: Physiology-based evaluation in stable ischemic heart disease is transforming percutaneous cardiovascular intervention (PCI). Fractional flow reserve (FFR)-guided PCI is associated with more appropriate and beneficial outcomes at lower costs. The surgical community can no longer ignore this development. We review evidence for the rationale, practicality and appropriateness of FFR-guided coronary artery bypass grafting (CABG), as compared with the current conventional, anatomy-based strategy for surgical revascularization...
November 2013: Current Opinion in Cardiology
https://www.readbyqxmd.com/read/24077607/intraaortic-balloon-pump-use-in-high-risk-percutaneous-coronary-intervention
#8
REVIEW
Sumeet Sharma, Matthew Lumley, Divaka Perera
PURPOSE OF REVIEW: Despite the long-term availability and clinical usage of intraaortic balloon pump (IABP) counterpulsation, there is a paucity of randomized trial evidence for its use. Here, we will review the latest evidence for its usage in different clinical settings. RECENT FINDINGS: There have been decades of nonrandomized and observational data available, but only in the last 3 years has there been availability of randomized evidence for IABP use in acute myocardial infarction (AMI) with cardiogenic shock, ST elevation acute coronary syndromes (STE-ACS) without shock and high-risk percutaneous coronary intervention (PCI) cohorts...
November 2013: Current Opinion in Cardiology
https://www.readbyqxmd.com/read/20200382/comparison-of-dopamine-and-norepinephrine-in-the-treatment-of-shock
#9
RANDOMIZED CONTROLLED TRIAL
Daniel De Backer, Patrick Biston, Jacques Devriendt, Christian Madl, Didier Chochrad, Cesar Aldecoa, Alexandre Brasseur, Pierre Defrance, Philippe Gottignies, Jean-Louis Vincent
BACKGROUND: Both dopamine and norepinephrine are recommended as first-line vasopressor agents in the treatment of shock. There is a continuing controversy about whether one agent is superior to the other. METHODS: In this multicenter, randomized trial, we assigned patients with shock to receive either dopamine or norepinephrine as first-line vasopressor therapy to restore and maintain blood pressure. When blood pressure could not be maintained with a dose of 20 microg per kilogram of body weight per minute for dopamine or a dose of 0...
March 4, 2010: New England Journal of Medicine
1
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"